Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Abbott Serlect

Executive Summary

Abbott Serlect: NDA 20-644 for the antipsychotic agent sertindole will be discussed by FDA's Psychopharmacologic Drugs Advisory Committee July 15. On July 16, the committee will discuss the recommended modification in the frequency of required white blood cell count monitoring for Sandoz' antischizophrenic agent Clozaril (clozapine). The meeting will take place at the Holiday Inn in Silver Spring, Md., beginning at 8:30 a.m. both days...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel